SS

Stacey Seltzer

Board Member at Reneo Pharmaceuticals

New York, New York

Overview

Work Experience

RP

Reneo Pharmaceuticals

  • Board Member

    2020 - Current

GP

Gurnet Point Capital

  • Partner

    2022 - 2024

AC

Aisling Capital

  • Partner

    2014 - 2022

  • Principal

    2008 - 2014

AT

Aimmune Therapeutics

  • Board Member

    2015 - 2020

Miramar Labs

  • Board Member

    2011 - 2017

SP

Schering Plough

  • Associate Director, US Marketing

    2007 - 2008

  • Senior Manager, Global Licensing

    2005 - 2007

  • Management Associate

    2004 - 2005

Akceli

  • Director, Business Development

    2001 - 2002

McKinsey & Company

  • Business Analyst

    1998 - 2000

Education

Investments

Aimmune Therapeutics

Series B

Total Funding: $80M

Agile Therapeutics

Series C

Total Funding: $110M

Relevant Websites